↓ Skip to main content

Evaluation of intravenous voriconazole in patients with compromised renal function

Overview of attention for article published in BMC Infectious Diseases, January 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of intravenous voriconazole in patients with compromised renal function
Published in
BMC Infectious Diseases, January 2013
DOI 10.1186/1471-2334-13-14
Pubmed ID
Authors

Craig M Lilly, Verna L Welch, Thomas Mayer, Paul Ranauro, Joanne Meisner, David R Luke

Abstract

Incorporation of the solubilizing excipient, sulfobutylether-β-cyclodextrin (SBECD), in the intravenous (IV) formulation of voriconazole has resulted in the recommendation that this formulation be used with caution in patients with creatinine clearances (Clcr) < 50 mL/min. This study evaluated the safety of IV voriconazole compared with two other IV antifungals not containing SBECD in patients with compromised renal function.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
Denmark 1 4%
Unknown 21 91%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 22%
Other 5 22%
Student > Ph. D. Student 3 13%
Researcher 3 13%
Student > Postgraduate 3 13%
Other 4 17%
Readers by discipline Count As %
Medicine and Dentistry 16 70%
Unspecified 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Agricultural and Biological Sciences 1 4%
Business, Management and Accounting 1 4%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2013.
All research outputs
#2,670,567
of 5,037,615 outputs
Outputs from BMC Infectious Diseases
#1,457
of 2,669 outputs
Outputs of similar age
#143,085
of 288,996 outputs
Outputs of similar age from BMC Infectious Diseases
#121
of 206 outputs
Altmetric has tracked 5,037,615 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,669 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,996 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 206 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.